Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The placebo effect is also very real, especially with pain
For patients with type 2 diabetes or prediabetes, this dual benefit of weight loss and glycemic control is particularly advantageous
In SURMOUNT-5, conducted in adults with obesity but without type 2 diabetes, tirzepatide produced a least-squares mean weight change of 20.2% at 72 weeks versus 13.7% with semaglutide
When women with obesity lose about 10% of their body weight, symptoms such as irregular periods and imbalanced estrogen may improve
US$ 24.85
US$ 21.62
US$ 27.61
US$ 27.02
US$ 29.51
US$ 22.05
US$ 27.83
US$ 23.68
